Ethical problems in bone marrow transplantation in children

Area of Science:

• Pediatric Hematology/Oncology
• Medical Ethics
• Transplantation Law

Background:

• Pediatric hematological and oncological diseases often necessitate advanced treatments like bone marrow transplantation (BMT).
• BMT is a critical therapy for incurable or treatment-resistant conditions in children.
• Ethical and legal complexities arise, particularly when a related donor is unavailable or is a minor.

Purpose of the Study:

• To explore the ethical and legal considerations surrounding pediatric bone marrow transplantation.
• To highlight the importance of informed consent in allogeneic BMT, especially involving child donors.
• To emphasize the necessary infrastructure and expertise for BMT centers.

Main Methods:

• Review of ethical and legal issues in pediatric BMT.
• Analysis of consent procedures for donors and recipients, including minors.
• Discussion of requirements for BMT units and the ethical implications of 'last hope' treatments.

Main Results:

• Allogeneic BMT requires consent from both the donor and the recipient's parents.
• When the donor is a minor, parental consent is essential, with minimal risks primarily linked to general anesthesia.
• Informed consent processes are typically reviewed and approved by institutional Ethics Committees.

Conclusions:

• Pediatric BMT involves significant ethical and legal considerations, particularly concerning consent.
• Rigorous ethical oversight and comprehensive informed consent are paramount for patient and donor safety.
• Experienced centers with robust support systems are essential for successful BMT outcomes.